Understanding Patient Compliance and Persistence with Osteoporosis Therapy

Author： Gold Deborah T.  

Publisher： Adis International

ISSN： 1170-229X

Source： Drugs & Aging, Vol.28, Iss.4, 2011-04, pp. : 249-255

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Patient Compliance and Persistence with Anti-hyperglycemic Therapy: Evaluation of a Population of Type 2 Diabetic Patients

By Dailey G   Kim MS   Lian JF  

The Journal of International Medical Research, Vol. 30, Iss. 1, 2002-01 ,pp. : 71-79

Field House Publishing

Access to resources Recommend Favorite

Compliance compromising management of osteoporosis

By  

Inpharma, Vol. 1, Iss. 1556, 2006-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Patient Compliance with Drug Therapy in Schizophrenia: Economic and Clinical Issues

By Lindström E.  

PharmacoEconomics, Vol. 18, Iss. 2, 2000-08 ,pp. : 105-124

Adis International

Access to resources Recommend Favorite

Future Developments in Osteoporosis Therapy

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 9, Iss. 4, 2009-01 ,pp. : 371-384

Bentham Science Publishers

Access to resources Recommend Favorite

A Competing Risks Prescription Refill Model of Compliance and Persistence

By Barron T. Ian   Bennett Kathleen   Feely John  

Value in Health, Vol. 13, Iss. 6, 2010-09 ,pp. : 796-804

Blackwell Publishing

Access to resources Recommend Favorite